Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
262.14
+5.09 (1.98%)
Feb 17, 2026, 10:08 AM EST - Market open
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $6.93 billion as of February 17, 2026. Its market cap has decreased by -30.91% in one year.
Market Cap
6.93B
Enterprise Value
6.77B
1-Year Change
-30.91%
Ranking
Category
Stock Price
$262.14
Market Cap Chart
Since February 17, 2021, Bio-Rad Laboratories's market cap has decreased from $19.56B to $6.93B, a decrease of -64.58%. That is a compound annual growth rate of -18.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.92B | -15.16% |
| Dec 31, 2025 | 8.16B | -11.13% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 15.65% |
| Feb 17, 2021 | 19.56B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smith & Nephew | 15.35B |
| Penumbra | 13.29B |
| Globus Medical | 11.79B |
| Masimo | 6.99B |
| Bio-Rad Laboratories | 6.92B |
| Glaukos | 6.28B |
| Bruker | 5.55B |
| iRhythm Holdings | 4.65B |